Amgen Inc (NASDAQ:AMGN) - Share price - Overview

Stock Report

Amgen Inc AMGN

Last Price
$167.29

Day Change
-0.52|-0.31%

As of 18/08/2017
18:24:44 EDT | USD
Minimum 15 Minutes Delay.

Last Close167.81
Day Range166.52 - 168.43
Mkt Cap122.10Bil
52-Wk Range133.64 - 184.21
Yield %2.66
ISINUS0311621009
Volume1,741,936
P/E15.24
P/S5.40
P/CF11.89

Share Price

Financials
201420152016
More ...
Income Statement
Revenue20,063.0021,662.0022,991.00
Operating Income6,191.008,470.009,794.00
Net Income5,158.006,939.007,722.00
Basic EPS6.809.1510.32
Avg. Diluted Shares Outstanding770766754
Balance Sheet
Current Assets34,713.0038,518.0046,010.00
Non Current Assets34,296.0033,058.0031,616.00
Total Assets69,009.0071,576.0077,626.00
Current Liabilities7,008.008,667.0011,204.00
Total Liabilities43,231.0043,493.0047,751.00
Total Equity25,778.0028,083.0029,875.00
Cash Flow
Operating Cash Flow8,555.009,077.0010,354.00
Capital Expenditure-1,003.00-649.00-837.00
Free Cash Flow7,552.008,428.009,517.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

19,200
Key Stats
More ...
Price/Earning TTM15.19
Price/Book3.86
Price/Sales TTM5.42
Rev Growth (3 year avg)7.17
EPS Growth (3 year avg)-
Operating Margin % TTM42.60
Net Margin % TTM33.59
ROE TTM26.65
Debt/Equity1.01
Dividends
PreviousLatest
More ...
Declared Date07/03/1728/07/17
Ex-Div15/05/1715/08/17
Paid08/06/1708/09/17
Amnt1.151.15
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.